ProShare Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$316K Sell
4,846
-454
-9% -$29.6K ﹤0.01% 1406
2025
Q1
$355K Sell
5,300
-1,232
-19% -$82.5K ﹤0.01% 1298
2024
Q4
$361K Buy
6,532
+1,469
+29% +$81.2K ﹤0.01% 1486
2024
Q3
$302K Buy
5,063
+1,493
+42% +$89.1K ﹤0.01% 1457
2024
Q2
$227K Sell
3,570
-877
-20% -$55.8K ﹤0.01% 1465
2024
Q1
$307K Buy
4,447
+404
+10% +$27.9K ﹤0.01% 1417
2023
Q4
$223K Buy
4,043
+472
+13% +$26K ﹤0.01% 1578
2023
Q3
$207K Buy
+3,571
New +$207K ﹤0.01% 1442
2020
Q1
Sell
-4,106
Closed -$253K 1188
2019
Q4
$253K Sell
4,106
-442
-10% -$27.2K ﹤0.01% 1442
2019
Q3
$331K Sell
4,548
-50
-1% -$3.64K ﹤0.01% 1173
2019
Q2
$378K Sell
4,598
-534
-10% -$43.9K ﹤0.01% 1129
2019
Q1
$362K Buy
5,132
+39
+0.8% +$2.75K ﹤0.01% 1164
2018
Q4
$229K Sell
5,093
-914
-15% -$41.1K ﹤0.01% 1297
2018
Q3
$340K Sell
6,007
-293
-5% -$16.6K ﹤0.01% 1285
2018
Q2
$421K Sell
6,300
-389
-6% -$26K ﹤0.01% 1204
2018
Q1
$389K Sell
6,689
-1,044
-14% -$60.7K ﹤0.01% 1202
2017
Q4
$498K Buy
7,733
+453
+6% +$29.2K ﹤0.01% 1135
2017
Q3
$382K Buy
7,280
+479
+7% +$25.1K ﹤0.01% 1059
2017
Q2
$318K Sell
6,801
-477
-7% -$22.3K ﹤0.01% 1133
2017
Q1
$360K Sell
7,278
-1,822
-20% -$90.1K ﹤0.01% 1159
2016
Q4
$552K Buy
9,100
+897
+11% +$54.4K 0.01% 1032
2016
Q3
$544K Sell
8,203
-1,489
-15% -$98.7K 0.01% 923
2016
Q2
$541K Buy
9,692
+81
+0.8% +$4.52K 0.01% 934
2016
Q1
$324K Sell
9,611
-962
-9% -$32.4K ﹤0.01% 1175
2015
Q4
$477K Buy
10,573
+946
+10% +$42.7K 0.01% 1054
2015
Q3
$380K Sell
9,627
-636
-6% -$25.1K 0.01% 1032
2015
Q2
$637K Sell
10,263
-462
-4% -$28.7K 0.01% 988
2015
Q1
$671K Buy
10,725
+1,752
+20% +$110K 0.01% 1039
2014
Q4
$506K Buy
+8,973
New +$506K 0.01% 1192